Labiotech.eu

News and Trends 22 Apr 2020

€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating

The French startup Phost’in Therapeutics has raised €10.3M to take its cancer immunotherapy drug against solid tumors into clinical trials within a year. Led by the US-Japanese venture capital firm Remiges Ventures, the Series A round also included contributions from Japanese investment firm ANRI and French private equity investor Irdi Soridec Gestion. The cash injection […]

April 22, 2020 - 3 minutesmins - By Anita Chakraverty

News and Trends 21 Apr 2020

Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia

The Swiss pharmaceutical company Idorsia has announced that its drug candidate daridorexant significantly improved sleep onset, sleep quality, and daytime functioning of insomnia patients in a pivotal phase III trial. The trial recruited 930 adult patients with insomnia. The company used a technique called polysomnography to measure the time taken to fall asleep and sleep […]

April 21, 2020 - 3 minutesmins - By Karen O’Hanlon Cohrt

In Depth 20 Apr 2020

How Has Coronavirus Affected Europe’s Biotech Stocks?

The information flow about the coronavirus pandemic is truly electrifying, with big public market swings in the life sciences industry. That said, exactly what sort of impact is the disease known as Covid-19 having on biotech stocks? In the last few months, the Covid-19 pandemic situation has rocked the stock markets, causing intense swings across […]

April 20, 2020 - 12 minutesmins - By Carlos de Rojas

News and Trends 17 Apr 2020

French Biotech Licenses Microbiome Therapeutic to Treat Mood Disorders

The microbiome company LNC Therapeutics has entered into a licensing agreement to use a specific strain of gut bacteria for the treatment of mood disorders such as depression and anxiety. The agreement was made with the National Research Council (CSIC) in Spain, and gives LNC Therapeutics exclusive research, manufacturing, and commercialization rights of the microbiome-based […]

April 17, 2020 - 3 minutesmins - By Laura Cowen

News and Trends 17 Apr 2020

Is New Enzyme Technology Key to Solving Society’s Plastic Problem?

A new type of enzyme developed by the French company Carbios can break down more than 90% of the plastic PET, commonly used to make plastic bottles, and the byproducts can then be recycled into new PET. But how far does this go towards solving our plastic waste problem? PET, or polyethylene terephthalate, comprises around […]

April 17, 2020 - 4 minutesmins - By Helen Albert

Startup Scout 17 Apr 2020

Amphista Therapeutics Is Silencing Disease Proteins to Treat Cancer

Amphista Therapeutics, based in Glasgow, Scotland, is the latest company to develop drugs called PROTACs, which are designed to make the cell degrade harmful proteins to treat cancer. Small molecule drugs have shown incredible potential for the treatment of cancer by blocking harmful proteins in the cell. However, many promising protein targets for cancer treatments […]

April 17, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 16 Apr 2020

Irish Biotech Raises €18M to Develop Non-Viral Cell Therapy Technology

The Irish company Avectas has closed a Series C round to develop cell therapies that don’t need viral vectors — a common bottleneck in cell therapy manufacturing. The fundraise of approximately €18M brings Avectas’ total equity funding to around €37M. The round was led by the company’s current shareholders, which include the serial life sciences […]

April 16, 2020 - 2 minutesmins - By Jonathan Smith

neurofibromatosis healx ai drug repurposing

News and Trends 15 Apr 2020

Healx Deploys AI Drug Discovery Technology Against Rare Nerve Disease

The AI-driven drug repurposing company Healx has teamed up with the global Children’s Tumor Foundation (CTF) to develop new treatments for the genetic disease neurofibromatosis type 1, right after the FDA approved the first-ever drug for the condition. In the collaboration, the UK biotech will use its AI-driven pharmacology expertise to speed a candidate drug […]

April 15, 2020 - 3 minutesmins - By Jonathan Smith

Interview 15 Apr 2020

Investing in the Microbiome in the Age of Covid-19 and Beyond

For Isabelle de Cremoux, CEO and Managing Partner at Seventure Partners, 2020 was going to be an important year for microbiome research. However, the global coronavirus pandemic arrived, presenting one of the greatest unforeseen challenges in human history. I spoke to her about the microbiome field’s progress and the legacy of the Covid-19 pandemic going […]

April 15, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin

Expert Advice 13 Apr 2020

Need Funding to Fight Coronavirus? These Initiatives Have You Covered

As coronavirus disease continues to take its devastating toll across the globe, there is a clear need for new strategies to curb it. Thankfully, initiatives are springing up around the world that can support European startups in the search for new methods of diagnosis, treatment, and prevention. Coronavirus disease, also known as Covid-19, is wreaking […]

April 13, 2020 - 8 minutesmins - By External Contributor

boehringer ingelheim cancer vaccine amal therapeutics

News and Trends 10 Apr 2020

Coronavirus Pandemic Bites into European Cancer Research

The UK funder Cancer Research UK and Swedish oncology biotech Alligator Bioscience have independently announced cuts to payroll and research costs due to the coronavirus disease pandemic. Cancer Research UK is cutting research funding by €50M after calculating it will lose a quarter or more of its annual fundraising income — or €137m — through […]

April 10, 2020 - 4 minutesmins - By Anita Chakraverty

epigenetics review cambridge epigenetix oryzon1

News and Trends 9 Apr 2020

Two European Alzheimer’s Disease Treatments Show Promise in Phase II

An epigenetics drug developed by the Spanish biopharmaceutical company Oryzon has reduced aggressive behavior in patients with Alzheimer’s disease and improved the experience of their caregivers in a phase IIa trial. At the same time, an Alzheimer’s vaccine developed by the Austrian biotech Axon Neuroscience has lowered a key blood biomarker of neurodegeneration by almost […]

April 9, 2020 - 4 minutesmins - By David Kirk

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating

Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia

How Has Coronavirus Affected Europe’s Biotech Stocks?

French Biotech Licenses Microbiome Therapeutic to Treat Mood Disorders

Is New Enzyme Technology Key to Solving Society’s Plastic Problem?

Amphista Therapeutics Is Silencing Disease Proteins to Treat Cancer

Irish Biotech Raises €18M to Develop Non-Viral Cell Therapy Technology

Healx Deploys AI Drug Discovery Technology Against Rare Nerve Disease

Investing in the Microbiome in the Age of Covid-19 and Beyond

Need Funding to Fight Coronavirus? These Initiatives Have You Covered

Coronavirus Pandemic Bites into European Cancer Research

Two European Alzheimer’s Disease Treatments Show Promise in Phase II

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!